Stem cell technology can reduce R&D costs of pharma sector by 25%
PharmaBiz Tue, 19 Feb 2008 6:52 PM PST
Stem cell technology can reduce the expenses on pharmaceutical research by 25 per cent with savings up to $225 million each year, according Prof. McGuckin, scientist, Newcastle Centre for Cord Blood International Centre for Life, United Kingdom. |
UTMB gets grant for stem cell research
Galveston County Daily News Tue, 19 Feb 2008 9:54 PM PST
GALVESTON — A $500,000 grant from the Cullen Foundation will support neurological stem cell research at the University of Texas Medical Branch by funding the purchase of an advanced microscope and supporting a postdoctoral fellow who assists in the studies to optimize stem cell therapy. |
Panel to discuss embryonic stem cell research
Battle Creek Enquirer Tue, 19 Feb 2008 2:00 PM PST
ALBION — An open public forum to discuss the scientific benefits of embryonic stem cell research will be held at 7 p.m. Wednesday in the Albion College Towsley Hall Auditorium, 611 E. Porter St. in Albion. |
Harvest Technologies to Present at ''3rd Annual Stem Cell Summit''
Centre Daily Times Tue, 19 Feb 2008 7:42 AM PST
Harvest Technologies Corp. (www.harvesttech.com) announced today its President, Gary Tureski, will present at the Third Annual Stem Cell Summit, Hilton New York, on Tuesday, Feb. 26, 2008. The annual Stem Cell Summit brings together the leading industry, investment, practitioner, and research innovators within the rapidly expanding field of stem cells. |
Invitrogen Launches Human Stem Cell cDNA Libraries
BioresearchOnline Tue, 19 Feb 2008 5:27 AM PST
Invitrogen Corporation announced the launch of its SuperScript Human Stem Cell cDNA Libraries. The high-quality cDNA libraries consist of complimentary DNA isolated from commonly used, well-characterized human embryonal carcinoma (hEC) and human embryonic stem cell (hESC) lines |
New stem cell trials expected in Scotland
Moldova.org Tue, 19 Feb 2008 8:51 AM PST
Scottish scientists are moving toward stem cell therapy trials designed to mend shattered bones and damaged cartilage.Researchers involved in the $2.7 million project at the University of Edinburgh expect to initiate a clinical trial within two years.The scientists said their research could have a major impact on treating conditions such as osteoarthritis, as well as treating trauma victims ... |
Harvest Technologies to Present at ''3rd Annual Stem Cell Summit'': President Gary Tureski to review the scientific ...
PRWeb Tue, 19 Feb 2008 10:10 AM PST
Harvest Technologies Corp. ( www.harvesttech.com ) announced today its President, Gary Tureski, will present at the Third Annual Stem Cell Summit, Hilton New York, on Tuesday, Feb. 26, 2008. The annual Stem Cell Summit brings together the leading industry, investment, practitioner, and research innovators within the rapidly expanding field of stem cells. (PRWeb Feb 19, 2008) Read the full ... |
| |
|
